Viewing Study NCT02191150


Ignite Creation Date: 2025-12-24 @ 4:57 PM
Ignite Modification Date: 2026-02-23 @ 8:48 AM
Study NCT ID: NCT02191150
Status: COMPLETED
Last Update Posted: 2016-02-08
First Post: 2014-07-07
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of Haemodialysis Patients Switching From Aranesp to Biosimilar
Sponsor: Amgen
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Anaemia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Anaemia, Chronic Kidney Disease, Switching, Aranesp, Darbepoetin Alfa, Epoetin Alfa … View